Synthesis, Antibacterial, and Antimonooxidase Activity of 4-(2-Methyl-1,3-oxazol-5-yl)benzenesulfonamide

被引:1
|
作者
Gasilina, O. A. [1 ,3 ]
Romanycheva, A. A. [1 ]
Shetnev, A. A. [1 ,2 ]
Korsakov, M. K. [1 ,3 ]
机构
[1] KD Ushinsky Yaroslavl State Pedag Univ, Yaroslavl 150000, Russia
[2] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia
[3] Kosygin State Univ Russia, Moscow 115035, Russia
基金
俄罗斯科学基金会;
关键词
sulfonamides; carbonic anhydrase inhibitors; antibiotic potentiation; anti-MAO effect; CARBONIC-ANHYDRASE IX; BENZENESULFONAMIDES; INHIBITORS; POTENT;
D O I
10.1134/S1070363223110038
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new method for obtaining 4-(2-methyl-1,3-oxazol-5-yl)benzenesulfonamide, an antiglaucomatous drug candidate oxazopt, was developed using a diazotization reaction. A combined potentiated effect of the antimicrobial action of carbapenems (meropenem) and aminoglycosides (gentamicin) against antibiotic-resistant gram-positive bacteria Enterococcus faecium, Enterococcus faecalis and gram-negative bacteria Escherichia coli, and antimonooxidase effect in vitro was revealed for this compound.
引用
收藏
页码:2749 / 2755
页数:7
相关论文
共 50 条
  • [1] Synthesis, Antibacterial, and Antimonooxidase Activity of 4-(2-Methyl-1,3-oxazol-5-yl)benzenesulfonamide
    O. A. Gasilina
    A. A. Romanycheva
    A. A. Shetnev
    M. K. Korsakov
    Russian Journal of General Chemistry, 2023, 93 : 2749 - 2755
  • [2] 4-[(2,4-Dimethyl-1,3-oxazol-5-yl)methyl]-4-hydroxy-2-methylisoquinoline-1,3(2H,4H)-dione
    Fun, Hoong-Kun
    Goh, Jia Hao
    Yu, Haitao
    Zhang, Yan
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O724 - U1396
  • [3] 4-[(1,3-Dioxoisoindolin-2-yl)methyl]benzenesulfonamide
    Mague, Joel T.
    Abdel-Aziz, Alaa A. -M.
    El-Azab, Adel S.
    EI-Sherbeny, Magda A.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O291 - +
  • [4] Study of biotransformation of new selective carbonic anhydrase II inhibitor 4-(2-methyl-1,3-oxazole-5-yl)-benzenesulfonamide
    Khokhlov, A. L.
    Yaichkov, I. I.
    Shetnev, A. A.
    Ivanovskiy, S. A.
    Korsakov, M. K.
    Gasilina, O. A.
    Volkhin, N. N.
    Petukhov, S. S.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2023, 11 (03): : 240 - 254
  • [5] 4-Methyl-N-{4-[(5-methyl-1,2-oxazol-3yl)sulfamoyl] phenyl} benzenesulfonamide
    Sohail, Muhammad
    Asghar, Muhammad Nadeem
    Tahir, M. Nawaz
    Shafique, Muhammad
    Ashfaq, Muhammad
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O693 - U1998
  • [6] Twisted structure of a substituted 2-chloro-3-(4-chloro-2-methyl-1,3-oxazol-5-yl)-1H-indole
    Radspieler, Alexander
    Ziemer, Burkhard
    Liebscher, Juergen
    Acta Crystallographica, Section C: Crystal Structure Communications, 1998, 54 (pt 9): : 1351 - 1353
  • [7] Highly hydrophilic 1,3-oxazol-5-yl benzenesulfonamide inhibitors of carbonic anhydrase II for reduction of glaucoma-related intraocular pressure
    Kalinin, Stanislav
    Valtari, Annika
    Ruponen, Marika
    Toropainen, Elisa
    Kovalenko, Alexander
    Nocentini, Alessio
    Gureev, Maxim
    Dar'in, Dmitry
    Urtti, Arto
    Supuran, Claudiu T.
    Krasavin, Mikhail
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (21)
  • [8] Twisted structure of a substituted 2-chloro-3-(4-chloro-2-methyl-1,3-oxazol-5-yl)-1H-indole
    Radspieler, A
    Ziemer, B
    Liebscher, J
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 1351 - 1353
  • [9] 2-Methyl-1,3-benzoxazol-4-yl diphenylphosphinate
    Kleinhans, Dewald J.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O339 - U387
  • [10] Synthesis and cholinergic affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine, 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of their lodomethylatest
    Dei, S
    Bellucci, C
    Buccioni, M
    Ferraroni, M
    Gualtieri, F
    Guandalini, L
    Manetti, D
    Matucci, R
    Romanelli, MN
    Scapecchi, S
    Teodori, E
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (14) : 3153 - 3164